Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Head & Face Medicine
Published in: Head & Face Medicine 1/2010

Open Access 01-12-2010 | Review

Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma

Authors: Liviu Feller, Neil H Wood, Razia AG Khammissa, Johan Lemmer

Published in: Head & Face Medicine | Issue 1/2010

Login to get access

Abstract

Human papillomavirus (HPV) infection of the mouth and oropharynx can be acquired by a variety of sexual and social forms of transmission. HPV-16 genotype is present in many oral and oropharyngeal squamous cell carcinomata. It has an essential aetiologic role in the development of oropharyngeal squamous cell carcinoma in a subset of subjects who are typically younger, are more engaged with high-risk sexual behaviour, have higher HPV-16 serum antibody titer, use less tobacco and have better survival rates than in subjects with HPV-cytonegative oropharyngeal squamous cell carcinoma. In this subset of subjects the HPV-cytopositive carcinomatous cells have a distinct molecular profile.
In contrast to HPV-cytopositive oropharyngeal squamous cell carcinoma, the causal association between HPV-16 and other high-risk HPV genotypes and squamous cell carcinoma of the oral mucosa is weak, and the nature of the association is unclear.
It is likely that routine administration of HPV vaccination against high-risk HPV genotypes before the start of sexual activity will bring about a reduction in the incidence of HPV-mediated oral and oropharyngeal squamous cell carcinoma.
This article focuses on aspects of HPV infection of the mouth and the oropharynx with emphasis on the link between HPV and squamous cell carcinoma, and on the limitations of the available diagnostic tests in identifying a cause-and-effect relationship of HPV with squamous cell carcinoma of the mouth and oropharynx.
Literature
1.
Steben M, Duarte-Franco E: Human papillomavirus infection: Epidemiology and pathophysiology. Gynecol Oncol. 2007, 107: S2-S5. 10.1016/j.ygyno.2007.07.067.CrossRefPubMed
2.
Walboomers JM, Jacobs MV, Manos MM, Bosch MS, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.CrossRefPubMed
3.
Monk BJ, Tewari KS: The spectrum and clinical sequelae of human papillomavirus infection. Gynecol Oncol. 2007, 107: S6-S13. 10.1016/j.ygyno.2007.07.076.CrossRefPubMed
4.
Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, Mao EJ, Fitzgibbons ED, Huang S, Beckmann AM, McDougall JK, Galloway DA: Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998, 90: 1626-1636. 10.1093/jnci/90.21.1626.CrossRefPubMed
5.
Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, Turek LP: Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004, 96: 449-455. 10.1093/jnci/djh074.CrossRefPubMed
6.
Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinoma worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005, 14: 467-475. 10.1158/1055-9965.EPI-04-0551.CrossRefPubMed
7.
Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Møller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001, 344: 1125-1131. 10.1056/NEJM200104123441503.CrossRefPubMed
8.
Syrjanen S: Human papillomavirus infections and oral tumours. Med Microbiol Immunol. 2003, 192: 123-128. 10.1007/s00430-002-0173-7.CrossRefPubMed
9.
Gillison ML: Human papillomavirus and prognosis of oropharyngealsquamous cell carcinoma: Implication for clinical research in head and neck cancer. J Clin Oncol. 2006, 24: 5623-5625. 10.1200/JCO.2006.07.1829.CrossRefPubMed
10.
Miller CS, Zeuss MS, White DK: Detection of HPV DNA in oral carcinoma using polymerase chain reaction together with in situ hybridization. Oral Surg Oral Med Oral Pathol. 1994, 77: 480-486. 10.1016/0030-4220(94)90227-5.CrossRefPubMed
11.
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zaharuk ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000, 92: 709-720. 10.1093/jnci/92.9.709.CrossRefPubMed
12.
Gillison ML, Lowy DR: A causal role for human papillomavirus in head and neck cancer. Lancet. 2004, 363: 1488-1489. 10.1016/S0140-6736(04)16194-1.CrossRefPubMed
13.
Syrjanen S: Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005, 32S: S59-S66. 10.1016/j.jcv.2004.11.017.CrossRef
14.
Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, Oggionni M, Rossini C, Cantù G, Squadrelli M, Quattrone P, Locati LD, Bergamini C, Olmi P, Pierotti MA, Pilotti S: High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006, 24: 5630-5636. 10.1200/JCO.2005.04.6136.CrossRefPubMed
15.
Syrjanen S: Human papillomaviruses in the head and neck carcinomas. N Engl J Med. 2007, 365: 1993-1995. 10.1056/NEJMe078004.CrossRef
16.
Miller SC, Johnstone BM: Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001, 91: 622-635. 10.1067/moe.2001.115392.CrossRefPubMed
17.
D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007, 356: 1944-1956. 10.1056/NEJMoa065497.CrossRefPubMed
18.
Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernández L, Idris A, Sánchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJ, Meijer CJ, Viscidi R, Muñoz N, Franceschi S, IARC Multicenter Oral Cancer Study Group: Human papillomavirus and oral cancer: The international agency for research on cancer multicenter study. J Natl Cancer Inst. 2003, 95: 1772-1783.CrossRefPubMed
19.
Cameron JE, Hagensee ME: Oral HPV complications in HIV-infected patients. Current HIV/AIDS Reports. 2008, 5: 126-131. 10.1007/s11904-008-0020-6.CrossRefPubMed
20.
Haddad RI, Shin DM: Recent advances in head and neck cancer. N Engl J Med. 2008, 359: 1143-1154. 10.1056/NEJMra0707975.CrossRefPubMed
21.
Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH: Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003, 104: 336-344. 10.1002/ijc.10960.CrossRefPubMed
22.
Hennessey PT, Westra WH, Califano JA: Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res. 2009, 88: 300-306. 10.1177/0022034509333371.CrossRefPubMedPubMedCentral
23.
Hobbs CG, Stern JA, Baily M, Heyderman RS, Birchall MA, Thomas SJ: Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006, 31: 461-462. 10.1111/j.1749-4486.2006.01246.x.CrossRefPubMed
24.
Rampias T, Sasaki C, Weinberger P, Psyrri A: E6 and E7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst. 2009, 101: 412-423. 10.1093/jnci/djp017.CrossRefPubMed
25.
Wang SS, Hildesheim A: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr. 2003, 31: 35-40.CrossRefPubMed
26.
Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A: Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favourable prognosis. J Clin Oncol. 2006, 24: 736-747. 10.1200/JCO.2004.00.3335.CrossRefPubMed
27.
Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, Shah KV, Gillison ML: Oral human papillomavirus infection in adults is associated with sexual behaviour and HIV serostatus. J Infect Dis. 2004, 189: 686-698. 10.1086/381504.CrossRefPubMed
28.
D'Souza G, Fakhry C, Sugar EA, Seaberg EC, Weber K, Minkoff HL: Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer. 2007, 121: 143-150. 10.1002/ijc.22667.CrossRefPubMed
29.
Fakhry C, D'Souza G, Sugar E, Weber K, Goshu E, Minkoff H, Wright R, Seaberg E, Gillison M: Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and negative women. J Clin Microbiol. 2006, 44: 4470-4485. 10.1128/JCM.01321-06.CrossRef
30.
Ha PK, Califano JA: The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med. 2004, 15: 188-196. 10.1177/154411130401500402.CrossRefPubMed
31.
Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, Campisi G: HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1998-2007). Ann Oncol. 2008, 19: 1681-1690. 10.1093/annonc/mdn372.CrossRefPubMed
32.
Pintos J, Black MJ, Sadeghi N, Ghadirian P, Zeitouni AG, Viscidi RP, Herrero R, Coutlee F, Franco EL: Human papillomavirus infection and oral cancer: a case control sudy in Montreal, Canada. Oral Oncol. 2008, 44: 242-250. 10.1016/j.oraloncology.2007.02.005.CrossRefPubMed
33.
Furnis CS, McClean MD, Smith JF, Bryan J, Nelson HH, Peters ES, Posner MR, Clark JR, Eisen EA, Kelsey KT: Human papillomavirus 16 and head and neck squamous cell carcinoma. In J Cancer. 2007, 120: 2386-2392.
34.
Campisi G, Panzarella V, Termine N: Letter to the editor - comment on "human papillomavirus in the oral mucosa of women with genital human papillomavirus lesions". Eur J Obstet Gynecol Reprod Biol. 2007, 130: 142-143. 10.1016/j.ejogrb.2006.08.020.CrossRefPubMed
35.
Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH: Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst. 2004, 96: 998-1006. 10.1093/jnci/djh183.CrossRefPubMed
36.
Vidal L, Gillison ML: Human papliiomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am. 2008, 22: 1125-1142. 10.1016/j.hoc.2008.08.006.CrossRefPubMed
37.
Charfi L, Jouffroy T, de Cremoux P, Le Peltier N, Thioux M, Freneaux P, Point D, Girod A, Rodriguez J, Sastre-Garau X: Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett. 2008, 260: 72-78. 10.1016/j.canlet.2007.10.028.CrossRefPubMed
38.
Sturgis EM, Cinciripini PM: Trends in head and neck cancer incidence in relation o smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer. 2007, 110: 1429-1435. 10.1002/cncr.22963.CrossRefPubMed
39.
Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX: Involvement of intact HPV 16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene. 2002, 21: 1510-1517. 10.1038/sj.onc.1205214.CrossRefPubMed
40.
Koskinen WJ, Chen RW, Leivo I, Makitie A, Back L, Kontio R, Suuronen R, Lindqvist C, Auvinen E, Molijn A, Quint WG, Vaheri A, Aaltonen LM: Prevalence and physical status of human papillomavirus in squamous cell carcinoma of the head and neck. Int J Cancer. 2003, 107: 401-406. 10.1002/ijc.11381.CrossRefPubMed
41.
Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ, Fuchs PG: Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer. 2001, 92: 2875-2884. 10.1002/1097-0142(20011201)92:11<2875::AID-CNCR10130>3.0.CO;2-7.CrossRefPubMed
42.
Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D, Califano JA: Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res. 2002, 8: 1203-1209.PubMed
43.
van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001, 93: 232-235. 10.1002/ijc.1313.CrossRefPubMed
44.
Stanley M: Prevention strategies against human papillomavirus: The effectiveness of vaccination. Gynecol Oncol. 2007, 107: S19-S23. 10.1016/j.ygyno.2007.07.068.CrossRefPubMed
45.
Haug CJ: Human papillomavirus vaccination - Reasons for caution. N Engl J Med. 2008, 359: 861-862. 10.1056/NEJMe0804638.CrossRefPubMed
46.
Ault KA: Long-term efficacy of human papillomavirus vaccination. Gynecol Oncol. 2007, 107: S27-S30. 10.1016/j.ygyno.2007.07.078.CrossRefPubMed
47.
The future 11 study group: Quadrivalent vaccine against human papillomavirus to prevent high grade cervical lesions. N Engl J Med. 2007, 356: 1915-1927. 10.1056/NEJMoa061741.CrossRef
48.
Giulliano AR: Human papillomavirus vaccination in males. Gynecol Oncol. 2007, 107: S19-S26. 10.1016/j.ygyno.2007.07.075.CrossRef
49.
Sawaya GF, Smith-McCune K: HPV-vaccination - more answers, more questions. N Engl J Med. 2007, 356: 1991-1993. 10.1056/NEJMe078060.CrossRefPubMed
50.
Baden LR, Curfman GD, Marrisey S, Drazen JM: Human papillomavirus vaccine - opportunity and challenges. N Engl J Med. 2007, 356: 1990-1991. 10.1056/NEJMe078088.CrossRefPubMed
Metadata
Title
Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma
Authors
Liviu Feller
Neil H Wood
Razia AG Khammissa
Johan Lemmer
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Head & Face Medicine / Issue 1/2010
Electronic ISSN: 1746-160X
DOI
https://doi.org/10.1186/1746-160X-6-15

Other articles of this Issue 1/2010

Head & Face Medicine 1/2010 Go to the issue

Short report

Fish-hook injuries: a risk for fishermen

Short report

Eyelid bags

Research

Characterization of bone repair in rat femur after treatment with calcium phosphate cement and autogenous bone graft

Research

The impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)

Review

3D digital stereophotogrammetry: a practical guide to facial image acquisition

Research

Gender specific quality of life in patients with oral squamous cell carcinomas